• Resmed is a global leader in digital health and cloud-connected medical devices
• Expanded business by developing and acquiring innovative products and solutions for respiratory disorders
• Acquired VirtuOx, a software-enabled independent diagnostic testing facility, to expand sleep and breathing health solutions

ResMed Inc. is a global leader in digital health and cloud-connected medical devices, designing innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. The company has a focus on sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic diseases, offering a range of products and solutions including CPAP systems, ventilation devices, diagnostic products, mask systems, and dental devices. ResMed has also expanded its business by developing or acquiring a number of innovative products and solutions for a broad range of respiratory disorders, as well as cloud-based health applications, software, and devices designed to provide connected care. In May 2025, the company acquired VirtuOx, a software-enabled independent diagnostic testing facility (IDTF) and provider of technology solutions to facilitate in-home and remote testing services for sleep, respiratory, cardiac, and other health conditions. This acquisition strengthens ResMed's position in the sleep and breathing health market by expanding its ability to offer end-to-end solutions, including home-based diagnostics and patient monitoring. ResMed employs more than 10,600 people and sells its products in more than 140 countries through a combination of wholly owned subsidiaries and independent distributors.